You are here

STARTUPS

Temasek leads US$85m investment round for gene therapy startup

Singapore

IMMUNE cell gene therapy startup Gracell Biotechnologies has raised US$85 million through a Series B round led by Singapore government investment firm Temasek Holdings.

Also taking part in the financing round were Lilly Asia Ventures, Kington Capital, King Star Capital...

sentifi.com

Market voices on: